A new and convenient synthetic way to 2-substituted thieno[2,3-b]indoles

  1. Roman A. Irgashev1,2,
  2. Arseny A. Karmatsky1,2,
  3. Gennady L. Rusinov1,2 and
  4. Valery N. Charushin1,2

1Postovsky Institute of Organic Synthesis, Ural Division of the Russian Academy of Sciences, Ekaterinburg, 620990, Russia
2Ural Federal University named after the First President of Russia, B. N. Yeltsin, Ekaterinburg, 620002, Russia

  1. Corresponding author email

Associate Editor: J. P. Wolfe
Beilstein J. Org. Chem. 2015, 11, 1000–1007. https://doi.org/10.3762/bjoc.11.112
Received 19 Mar 2015, Accepted 19 May 2015, Published 11 Jun 2015


A short and robust approach for the synthesis of 2-(hetero)aryl substituted thieno[2,3-b]indoles from easily available 1-alkylisatins and acetylated (hetero)arenes has been advanced. The two-step procedure includes the “aldol-crotonic” type of condensation of the starting materials, followed by treatment of the intermediate 3-(2-oxo-2-(hetero)arylethylidene)indolin-2-ones with Lawesson’s reagent. The latter process involves two sequential reactions, namely reduction of the C=C ethylidene double bond of the intermediate indolin-2-ones followed by the Paal–Knorr cyclization, thus affording tricyclic thieno[2,3-b]indoles.

Keywords: aldol-crotonic condensation; isatin; Lawesson’s reagent; methyl ketones; Paal–Knorr reaction; thieno[2,3-b]indole


8H-Thieno[2,3-b]indole is a fused heterocyclic system, which has attracted a considerable attention of researchers, mainly due to the fact that thieno[2,3-b]indole derivatives exhibit a wide range of biological properties, and can be regarded as promising compounds for agricultural or pharmacological applications. For example, the alkaloid thienodolin [1], isolated from the fermentation mixture of Streptomyces albogriseolus and characterized by Kanbe et al. [2,3], has shown to exhibit a plant-growth-regulation activity (Figure 1). Furthermore, it has been reported that some thienoindoles are therapeutically agents for treating diseases of the central nervous system [4], potential inhibitors of acetylcholine esterase and butyrylcholine esterase [5], compounds of this series exhibit as well anti-tuberculosis [6] and anti-inflammatory activities [7]. Another promising area for the use of thieno[2,3-b]indoles, as electron-rich heteroaromatics, is the design of photo- and electroactive compounds which can be applied in organic optoelectronic materials. Indeed, we have recently reported the synthesis of novel push–pull dyes IK-1,2 based on the thieno[2,3-b]indole ring system, as a donating part of dye-sensitized solar cells [8] (Figure 1). It should be noted that thieno[2,3-b]pyrrole and thieno[3,2-b]pyrrole ring systems have been incorporated in the structures of various fused polycyclic compounds (heteroacenes), which have been used as efficient hole-transport materials for organic light emitting diodes (OLEDs) or field effect transistors (OFETs) [9-15].


Figure 1: Natural and synthetic derivatives of thieno[2,3-b]indole.

Taking into account that the overwhelming majority of compounds for organic electronics are constructed from π-conjugated linear or angular fused aromatic and heteroaromatic units [16-19], the development of convenient synthetic ways to structures bearing several linked (het)aromatic units appears to be a very important issue. It means that synthetic methods should be based on a minimum number of steps (one-pot procedure as the perfect case), while the starting materials are supposed to be easily available.

A number of synthetic routes to thieno[2,3-b]indoles have been described in the literature, including oxidative cyclization of indolin-2-thiones 1 [20], radical or palladium catalyzed cyclization of 3-(2-bromoindol-3-yl)acrylonitriles 2 [21,22], intramolecular CH/NH-coupling in benzo[b]thiophenes 3 [23], AlCl3 catalyzed recyclization of 2-(2-isothiocyanatophenyl)furanes 4 [24], reductive cyclization of 3-(2-nirtophenyl)thiophenes 5 via nitrene intermediates [25,26], and condensation of 3-unsubstituted indolin-2-thione 6 with aliphatic α-bromoaldehydes, α-bromoketones [27] or 3-halochromones (Hlg = Cl, Br) [28] under basic conditions (Scheme 1). However, all synthetic methods mentioned above are based on using functionalized indoles, thiophenes, furans or chromone precursors, which require several steps to be prepared.


Scheme 1: Synthetic routes to thieno[2,3-b]indoles.

Results and Discussion

In this paper we wish to report a convenient, short and robust approach to 8-alkyl-2-(het)arylthieno[2,3-b]indoles from 1-alkylisatins and the corresponding acetylated (hetero)arenes which are easily accessible reagents, including commercially available ones. It is well known that the reaction of isatins 7 with methyl ketones 8 leads to the formation of aldol-type adducts 9 under catalysis with mild bases, such as secondary or tertiary amines. These adducts can be dehydrated easily by acidic agents to form crotonic condensation products, namely 3-(2-oxo-2-(hetero)arylethylidene)indolin-2-ones 10, which can undergo reduction of the C=C double bond in the presence of Na2S2O4 [29], H2/Pd(C) [30], or Me3P–H2O [31] (Scheme 2) into the corresponding indolin-2-ones 11. Compounds 11 bearing the fragment of 4-oxobutyramides (1,4-dicarbonyl derivatives) can be cyclized into thieno[2,3-b]indoles by using the Paal–Knorr reaction with such thionation agents, as P4S10 or Lawesson’s reagent. This four-step route to thieno[2,3-b]indoles via the formation of indoline-2-ones 11 from isatins and methyl ketones has previously been realized [32,33]. In particular, preparation of 2-methyl-8H-thieno[2,3-b]indole from unsubstituted isatin and acetone in 15% yield has been reported [32] (Scheme 2). Although it seems to be a very harmonious strategy, it has hardly a significant preparative interest, since the target compounds are formed from isatins 7 and ketones 8 in four steps in low yields.


Scheme 2: Synthesis and thionation of indodin-2-ones 11.

The formation of model thieno[2,3-b]indole 12a from 1-ethylisatin (7a) and acetophenone (8a) has been studied in details, as the first step of our research (Scheme 3). The conventional path [32] (Path C) leading to the aldol adduct 9a (which was further used without purification in all our experiments), its dehydration into 10a, reduction of the latter to indolin-2-ones 11a, and finally cyclization of 11a by action of Lawesson’s reagent (LR), resulting in the formation of the desired product 12a in an overall yield of 25%. We have found that treatment of compound 10a with Lawesson’s reagent in toluene solution under reflux for 1 h leads to 12a as well; however the best overall yield of 57% has only been reached (Path B). The evidence for the structure of 12a has been obtained unequivocally by X-ray crystallography analysis, thus supporting the data of 1H and 13C NMR spectroscopy (Figure 2).


Scheme 3: Synthetic paths to thieno[2,3-b]indole 12a. LR = Lawesson's reagent


Figure 2: Mercury [34] representation of the X-ray crystal structure of 12a. Thermal ellipsoids of 50% probability are presented.

The Lawesson’s reagent appears to act firstly as a source of hydrogen sulfide to reduce the C=C double bond in compound 10a, and secondly, as the thiation agent to form thieno[2,3-b]indole 12a by means of the Paal–Knorr reaction. Compound 9a has also been treated with the Lawesson's reagent in toluene to give the title product 12a via intermediacy of 10a in a low 10% yield, based on the starting isatin 7a (Path A). Also the one-pot synthesis (Path D) of compound 12a has been realized through treatment of isatin 7a with (phenacylidene)triphenylphosphorane 13 and subsequent cyclization of the intermediate 10a according the Path B. The yield of the target product 12a obtained by the one-port procedure proved to be close to that of 12a deriving from the Path B. Path D requires the more expensive phosphorane derivative 13 which is formed by pre-functionalization of acetophenone (8a), and this approach can be regarded as an alternative synthetic route just in some specific cases. Thus, the two-step approach to convert isatins 7 into thieno[2,3-b]indoles 12 via intermediacy of 10 (Path B) has been selected as the most effective and convenient one.

Thereafter, a series of thieno[2,3-b]indoles 12a–m bearing both electron-rich and electron-deficient (hetero)aromatic fragments at C-2 have been prepared in good to moderate yields via the two-step synthetic procedure (Path B, Scheme 3) from isatin 7a and the corresponding acetylated (hetero)arenes 8a–m. Dehydration of the initially obtained aldol-type adducts into 3-(2-oxo-2-(hetero)arylethylidene)indolin-2-ones 10 has been carried out in acetic acid solution with addition of hydrochloric acid (method A), or in CH2Cl2 solution with an excess of SOCl2 (method B), when compounds 10 failed to be obtained by method A (Table 1, Scheme 4). It should be noted that thieno[2,3-b]indole derivatives 12e,f bearing 4-CN- or 2-NO2-phenyl substituents at C-2 have been prepared in high yields from the appropriate indolin-2-ones 10e,f by treatment with Lawesson’s reagent under the current reaction conditions without displacement of CN- or NO2-groups (Table 1, entries 5 and 6).


Scheme 4: Two-step synthesis of 2-(hetero)aryl substituted thieno[2,3-b]indoles 12.

Table 1: Yields of thieno[2,3-b]indoles (T[2,3-b]I) 12 and their precursors 10.

Entry Keton 8 (Het)Ar Method for 10 Indolin-2-one 10 Yield of 10 (%) T[2,3-b]I 12 Yield of 12 (%)
1 8a Ph A 10a 63 12a 90
2 8b [Graphic 1] A 10b 65 12b 90
3 8c [Graphic 2] A 10c 69 12c 94
4 8d [Graphic 3] A 10d 57 12d 79
5 8e [Graphic 4] B 10e 75 12e 92
6 8f [Graphic 5] B 10f 81 12f 82
7 8g [Graphic 6] A 10g 74 12g 56
8 8h [Graphic 7] A 10h 91 12h 70
9 8i C6F5 A 10i 33 12i 77
11 8j [Graphic 8] A 10j 76 12j 75
10 8k [Graphic 9] A 10k 76 12k 74
12 8l [Graphic 10] B 10l 66 12l 61
13 8m [Graphic 11] B 10m 67 12m 60

Additionally, compounds 12n,o bearing one or two bromine atoms at C-5 or C-5,7 of the thieno[2,3-b]indole scaffold have been prepared successfully from the corresponding isatins 7b,c and acetophenone (8a) according to the synthetic procedure described above. Isatin 7c containing an n-hexyl substituent at the nitrogen atom has been applied to ensure a good solubility of the target product 12o, as well as of the intermediate 10o. It should be noted that bromination of 2-phenyl-substituted thieno[2,3-b]indole 12a led to a rather complicated mixture of compounds, and all attempts to reach bromination of compound 12a with an excess of Br-agent (e.g., Br2/1,4-dioxane, NBS/CHCl3) proved to be unsuccessful (Scheme 5).


Scheme 5: Synthesis of mono- and dibromo-substituted thieno[2,3-b]indoles 12n,o.


In summary, we have developed a convenient and robust synthetic approach to thieno[2,3-b]indoles, bearing a wide range of aromatic and heteroaromatic substituents at C-2 with various electronic characteristics. Target thieno[2,3-b]indoles have been synthesized from 3-(2-oxo-2-(hetero)arylethylidene)indolin-2-one by treatment of the latter with Lawesson’s reagent through a tandem reduction of the C=C double bond and the Paal–Knorr cyclization, thus affording tricyclic thieno[2,3-b]indoles. In its turn, the required indolin-2-ones have been prepared by a simple “aldol-crotonic” type of condensation of N-alkylated isatins with acetophenones or their heterocyclic analogues. This two-step approach provides an easy access to compounds of the family of electron-rich thieno[2,3-b]indoles, which are regarded as promising building-blocks for the development of new photo- and electrosensitive molecules, e.g., novel push–pull dyes for dye-sensitized solar cells.


General information

1H and 13C NMR spectra were obtained on Bruker DRX-400 and AVANCE-500 spectrometers with TMS as the internal standard. Elemental analysis was carried on an Eurovector EA 3000 automated analyzer. Mass spectrometry was performed using a Bruker maXis Impact HD spectrometer. Melting points were determined on Boetius combined heating stages and were not corrected. All solvents used were dried and distilled per standard procedures. IR spectra of samples (solid powders) were recorded on a Spectrum One Fourier transform IR spectrometer (Perkin Elmer) equipped with a diffuse reflectance attachment (DRA). X-ray diffraction analysis was performed on an automated X-ray diffractometer “Xcalibur E” on standard procedure.

General procedure for the synthesis of 3-(2-oxo-2-(hetero)arylethylidene)indolin-2-one 10a10o

The solution of 1-alkylisatin 7 (3 mmol), corresponding methyl ketone 8 (3 mmol) and N,N-diethylamine (0.062 mL, 0.6 mmol) in EtOH (15 mL) was stirred at room temperature for 48 h. The resulting mixture was concentrated under reduced pressure to obtain crude adduct 9 that was dehydrated without any purification according to method A or method B.

Method A (For the preparation of compounds 10a–d, 10g–k): A drop of hydrochloric acid was added to the suspension of crude adduct 9 in acetic acid (3 mL). The mixture was stirred at 100 °C for 30 min. After cooling the precipitate was filtered, washed with methanol and dried to give indolin-2-one 10 as an orange to dark-red solid.

1-Ethyl-3-(2-oxo-2-phenylethylidene)indolin-2-one (10a): Orange powder; Yield 525 mg (63%); mp 122–123 °C; 1H NMR (500 MHz, DMSO-d6) δ 8.08 (dd, J = 8.2, 0.9 Hz, 2H), 8.00 (d, J = 7.6 Hz, 1H), 7.79 (s, 1H), 7.73 (t, J = 7.4 Hz, 1H), 7.61 (t, J = 7.8 Hz, 2H), 7.47–7.40 (m, 1H), 7.13 (d, J = 7.9 Hz, 1H), 7.02 (t, J = 7.6 Hz, 1H), 3.79 (q, J = 7.2 Hz, 2H), 1.20 (t, J = 7.2 Hz, 3H); 13C NMR (126 MHz, DMSO-d6) δ 191.3, 166.3, 144.8, 136.8, 135.2, 134.1, 132.8, 129.1, 128.6, 126.8, 126.4, 122.1, 119.4, 109.2, 34.3, 12.5; IR(DRA): 493, 546, 577, 600, 630, 674, 691, 750, 779, 802, 877, 894, 949, 1009, 1067, 1089, 1108, 1159, 1181, 1228, 1293, 1347, 1446, 1469, 1482, 1578, 1600, 1620, 1658, 1701, 1823, 1921, 2873, 2933, 2975, 3056, 3114 cm−1; anal. calcd for C18H15NO2: C, 77.96; H, 5.45; N, 5.05; found: C, 77.66; H, 5.34; N, 5.08.

Method B (For the preparation of compounds 10e,f,l,–o): SOCl2 (0.28 ml, 3.9 mmol) was added to the solution of crude adduct 9 in dry CH2Cl2 (10 ml). The mixture was stirred at room temperature for 2 h. The resulting mixture was concentrated under reduced pressure and the residue was recrystallized in EtOH affording indolin-2-one 10 as orange to dark-red needles.

1-Ethyl-3-(2-(2-nitrophenyl)-2-oxoethylidene)indolin-2-one (10f): Red crystals; Yield 780 mg (81%); mp 120–121 °C; 1H NMR (400 MHz, DMSO-d6) δ 8.41 (d, J = 7.6 Hz, 1H), 8.21 (dd, J = 8.1, 0.7 Hz, 1H), 7.97–7.82 (m, 3H), 7.52 (td, J = 7.8, 1.0 Hz, 1H), 7.33 (s, 1H), 7.16 (d, J = 7.9 Hz, 1H), 7.11 (td, J = 7.7, 0.8 Hz, 1H), 3.77 (q, J = 7.2 Hz, 2H), 1.18 (t, J = 7.2 Hz, 3H); 13C NMR (126 MHz, DMSO-d6) δ 191.3, 166.4, 146.2, 145.5, 136.4, 135.8, 134.7, 133.9, 132.2, 128.8, 127.5, 125.8, 124.6, 122.4, 119.3, 109.3, 34.3, 12.5; IR(DRA): 473, 490, 548, 567, 584, 642, 675, 690, 746, 778, 846, 897, 932, 1002, 1058, 1080, 1128, 1164, 1187, 1224, 1285, 1324, 1348, 1391, 1414, 1464, 1485, 1502, 1584, 1608, 1629, 1653, 1709, 1780, 2648, 2837, 2939, 3021, 3402 cm−1; anal. calcd for C18H14N2O4: C, 67.07; H, 4.38; N, 8.69; found: C, 67.03; H, 4.12; N, 8.62.

Procedure for the one-pot synthesis of thieno[2,3-b]indole 12a

The solution of N-ethylisatin 7a (175 mg, 1 mmol) and (phenacylidene)triphenylphosphorane 13 (380 mg, 1 mmol) in dry toluene (5 mL) was stirred at room temperature for 48 h. Afterwards Lawesson’s reagent (405 mg, 1 mmol) was added and the mixture was refluxed for 1 h. The resulting solution was concentrated under reduced pressure and the residue was dissolved in CH2Cl2 and filtered through a silicagel pad. After evaporation of CH2Cl2 the crude product was purified by recrystallization from EtOH giving thieno[2,3-b]indoles 12a as white needles in 54% yield (150 mg).

General procedure for the synthesis of thieno[2,3-b]indoles 12a12o

The mixture of indolin-2-one 10 (2 mmol) and the Lawesson reagent (0.81 g, 2 mmol) in dry toluene (10 mL) was refluxed for 1 h. Upon refluxing the color of the solution turns from dark-red to yellowish. The resulting solution was concentrated under reduced pressure and the residue was dissolved in CH2Cl2 and filtered through a silicagel pad. After evaporation of CH2Cl2 the crude product was purified by recrystallization in EtOH affording thieno[2,3-b]indoles 12 as white to yellow needles.

8-Ethyl-2-phenyl-8H-thieno[2,3-b]indole (12a): Pale yellow needles; Yield 500 mg (90%); mp 82–83 °C; 1H NMR (500 MHz, CDCl3) δ 7.81 (d, J = 7.8 Hz, 1H), 7.67–7.57 (m, 3H), 7.42–7.33 (m, 3H), 7.30–7.26 (m, 1H), 7.25–7.21 (m, 1H), 7.21–7.16 (m, 1H), 4.28 (q, J = 7.3 Hz, 2H), 1.52 (t, J = 7.3 Hz, 3H); 1H NMR (500 MHz, DMSO-d6) δ 7.92 (s, 1H), 7.82 (d, J = 7.7 Hz, 1H), 7.66 (d, J = 7.3 Hz, 2H), 7.58 (d, J = 8.2 Hz, 1H), 7.44–7.36 (m, 2H), 7.28–7.21 (m, 2H), 7.19–7.11 (m, 1H), 4.34 (q, J = 7.2 Hz, 2H), 1.40 (t, J = 7.2 Hz, 3H); 13C NMR (126 MHz, DMSO-d6) δ 141.6, 140.8, 135.0, 134.8, 129.1, 126.7, 124.5, 123.4, 122.0, 121.5, 119.4, 119.1, 114.8, 109.9, 40.3, 13.6; IR(DRA): 474, 550, 567, 688, 746, 779, 835, 850, 905, 935, 999, 1015, 1049, 1078, 1100, 1131, 1162, 1191, 1207, 1252, 1330, 1350, 1377, 1393, 1409, 1439, 1477, 1496, 1524, 1595, 1671, 1734, 1776, 1867, 1894, 1942, 2888, 2928, 2972, 3029, 3053, 3748 cm−1; MS (+APCI): Calcd. for C18H15NS m/z 278.0998 [M + H], found m/z 278.1000 [M + H]; Crystal data for 12a: Colorless crystals 0.24 × 0.19 × 0.13 mm, θ < 25.6080°, 11563 reflections were collected, 7249 independent reflections (Rint 0.0245), completeness 100%. Crystal is monoclinic, space group Cc, a = 19.0695(13) Å, b = 30.6399(16) Å, c = 7.8360(4) Å, α = 90.00°, β = 106.777(6)°, γ = 90.00°, μ = 0.210 mm−1. The SHELXTL program [35] was used for solution and structure refinement. Refinement and the final R indices: R1 = 0.0432 [I>2σ(I)], wR2 = 0.1050 [I>2σ(I)], R1 = 0.0772 (all data), wR2 = 0.1355 (all data), S = 1.004. Deposition number CCDC 1054153 contains the supplementary crystallographic data for this structure. These data can be obtained free of charge from the Cambridge Crystallographic Data Centre via http://www.ccdc.cam.ac.uk/data_request/cif.

8-Ethyl-2-(2-nitrophenyl)-8H-thieno[2,3-b]indole (12f)

Yellow powder; Yield 530 mg (82%); mp 103–104 °C; 1H NMR (400 MHz, DMSO-d6) δ 7.94 (d, J = 7.8 Hz, 1H), 7.87 (d, J = 7.8 Hz, 1H), 7.77–7.71 (m, 2H), 7.67–7.53 (m, 3H), 7.33–7.27 (m, 1H), 7.22–7.13 (m, 1H), 4.37 (q, J = 7.2 Hz, 2H), 1.41 (t, J = 7.2 Hz, 3H); 13C NMR (126 MHz, DMSO-d6) δ 148.9, 143.0, 140.8, 132.5, 131.7, 128.6, 127.6, 127.0, 123.9, 123.3, 122.4, 121.3, 119.6, 119.4, 118.7, 110.0, 40.4, 13.5; IR(DRA): 482, 549, 567, 584, 646, 662, 685, 700, 738, 746, 770, 834, 845, 861, 919, 941, 953, 986, 1015, 1052, 1084, 1134, 1162, 1204, 1251, 1267, 1283, 1296, 1331, 1375, 1399, 1411, 1439, 1464, 1484, 1532, 1570, 1599, 1652, 1751, 1788, 1836, 1871, 1909, 1936, 1969, 2332, 2736, 2889, 2936, 2974, 2989, 3075, 3058 cm−1; Anal. calcd for C18H14N2O2S: C, 67.06; H, 4.38; N, 8.69; found: C, 66.98; H, 4.35; N, 8.72.

Supporting Information

Supporting Information File 1: Analytical data and copies of the 1H and 13C NMR spectra of the new compounds.
Format: PDF Size: 2.8 MB Download


This work was supported by the Russian Foundation for Basic Research (research projects No. 13-03-12434-ofi_m2, 13-03-96049-r_ural_a, 14-03-01017_A, 15-03-00924_А) and the Scientific Council of the President of the Russian Federation (grant МК-3043.2014.3).


  1. Engqvist, R.; Javaid, A.; Bergman, J. Eur. J. Org. Chem. 2004, 2589–2592. doi:10.1002/ejoc.200400073
    Return to citation in text: [1]
  2. Kanbe, K.; Naganawa, H.; Okamura, M.; Okami, Y.; Takeuchi, T.; Hattori, S.; Hamada, M. Biosci., Biotechnol., Biochem. 1993, 57, 632–635. doi:10.1271/bbb.57.632
    Return to citation in text: [1]
  3. Kanbe, K.; Naganawa, H.; Nakamura, K. T.; Okami, Y.; Takeuchi, T. Biosci., Biotechnol., Biochem. 1993, 57, 636–637. doi:10.1271/bbb.57.636
    Return to citation in text: [1]
  4. Jakobsen, P.; Kanstrup, A.; Faarup, P.; Olesen, P.; Lundbech, J. Antagonists, their preparation and use. U.S. Patent 5,783,575, June 21, 1998.
    Return to citation in text: [1]
  5. An-naka, M.; Yasuda, K.; Yamada, M.; Kawai, A.; Takamura, N.; Sugasawa, S.; Matsuoka, Y.; Iwata, H.; Fukushima, T. Heterocycles 1994, 39, 251–270. doi:10.3987/COM-94-S(B)20
    Return to citation in text: [1]
  6. Karthikeyan, S. V.; Perumal, S.; Shetty, K. A.; Yogeeswari, P.; Sriram, D. Bioorg. Med. Chem. Lett. 2009, 19, 3006–3009. doi:10.1016/j.bmcl.2009.04.029
    Return to citation in text: [1]
  7. Zhan, Z.-J.; Bian, H.-L.; Wang, J.-W.; Shan, W.-G. Bioorg. Med. Chem. Lett. 2010, 20, 1532–1534. doi:10.1016/j.bmcl.2010.01.097
    Return to citation in text: [1]
  8. Irgashev, R. A.; Karmatsky, A. A.; Kozyukhin, S. A.; Ivanov, V. K.; Sadovnikov, A.; Kozik, V. V.; Grinberg, V. A.; Emets, V. V.; Rusinov, G. L.; Charushin, V. N. Synth. Met. 2015, 199, 152–158. doi:10.1016/j.synthmet.2014.11.024
    Return to citation in text: [1]
  9. Qi, T.; Qiu, W.; Liu, Y.; Zhang, H.; Gao, X.; Liu, Y.; Lu, K.; Du, C.; Yu, G.; Zhu, D. J. Org. Chem. 2008, 73, 4638–4643. doi:10.1021/jo800622y
    Return to citation in text: [1]
  10. Qi, T.; Guo, Y.; Liu, Y.; Xi, H.; Zhang, H.; Gao, X.; Liu, Y.; Lu, K.; Du, C.; Yu, G.; Zhu, D. Chem. Commun. 2008, 6227–6229. doi:10.1039/b813683a
    Return to citation in text: [1]
  11. Du, C.; Chen, J.; Guo, Y.; Lu, K.; Ye, S.; Zheng, J.; Liu, Y.; Shuai, Z.; Yu, G. J. Org. Chem. 2009, 74, 7322–7327. doi:10.1021/jo901381f
    Return to citation in text: [1]
  12. Balaji, G.; Valiyaveettil, S. Org. Lett. 2009, 11, 3358–3361. doi:10.1021/ol901133m
    Return to citation in text: [1]
  13. Donaghey, J. E.; Ashrarf, R. S.; Kim, Y.; Huang, Z. G.; Nielsen, C. B.; Zhang, W.; Schroeder, B.; Grenier, C. R. G.; Brown, C. T.; D'Angelo, P.; Smith, J.; Watkins, S.; Song, K.; Anthopoulos, T. D.; Durrant, J. R.; Williams, C. K.; McCulloch, I. J. Mater. Chem. 2011, 21, 18744–18752. doi:10.1039/c1jm13428k
    Return to citation in text: [1]
  14. Xiong, Y.; Wu, Q.; Li, J.; Wang, S.; Gao, X.; Li, H. J. Org. Chem. 2013, 78, 752–756. doi:10.1021/jo3022154
    Return to citation in text: [1]
  15. Wetzel, C.; Mishra, A.; Mena-Osteritz, E.; Liess, A.; Stolte, M.; Würthner, F.; Bäuerle, P. Org. Lett. 2014, 16, 362–365. doi:10.1021/ol403153z
    Return to citation in text: [1]
  16. Anthony, J. E. Chem. Rev. 2006, 106, 5028–5048. doi:10.1021/cr050966z
    Return to citation in text: [1]
  17. Meyer, A.; Sigmund, E.; Luppertz, F.; Schnakenburg, G.; Gadaczek, I.; Bredow, T.; Jester, S.-S.; Höger, S. Beilstein J. Org. Chem. 2010, 6, 1180–1187. doi:10.3762/bjoc.6.135
    Return to citation in text: [1]
  18. Mason, C. R.; Li, Y.; O'Brien, P.; Findlay, N. J.; Skabara, P. J. Beilstein J. Org. Chem. 2011, 7, 1722–1731. doi:10.3762/bjoc.7.202
    Return to citation in text: [1]
  19. Cortizo-Lacalle, D.; Howells, C. T.; Pandey, U. K.; Cameron, J.; Findlay, N. J.; Inigo, A. R.; Tuttle, T.; Skabara, P. J.; Samuel, I. D. W. Beilstein J. Org. Chem. 2014, 10, 2683–2695. doi:10.3762/bjoc.10.283
    Return to citation in text: [1]
  20. Otani, T.; Kunimatsu, S.; Takahashi, T.; Nihei, H.; Saito, T. Tetrahedron Lett. 2009, 50, 3853–3856. doi:10.1016/j.tetlet.2009.04.045
    Return to citation in text: [1]
  21. Singh, P. P.; Yadav, A. K.; Ila, H.; Junjappa, H. Eur. J. Org. Chem. 2011, 4001–4007. doi:10.1002/ejoc.201100516
    Return to citation in text: [1]
  22. Yadav, A. K.; Ila, H.; Junjappa, H. Eur. J. Org. Chem. 2010, 338–344. doi:10.1002/ejoc.200901036
    Return to citation in text: [1]
  23. Kienle, M.; Wagner, A. J.; Dunst, C.; Knochel, P. Chem. – Asian J. 2011, 6, 517–523. doi:10.1002/asia.201000367
    Return to citation in text: [1]
  24. Butin, A. V.; Tsiunchik, F. A.; Abaev, V. T.; Zavodnik, V. E. Synlett 2008, 1145–1148. doi:10.1055/s-2008-1072720
    Return to citation in text: [1]
  25. Appukkuttan, P.; Van der Eycken, E.; Dehaen, W. Synlett 2005, 127–133. doi:10.1055/s-2004-836030
    Return to citation in text: [1]
  26. Smitrovich, J. H.; Davies, I. W. Org. Lett. 2004, 6, 533–535. doi:10.1021/ol036294l
    Return to citation in text: [1]
  27. Boeini, H. Z. Helv. Chim. Acta 2009, 92, 1268–1272. doi:10.1002/hlca.200800423
    Return to citation in text: [1]
  28. Savych, I.; Gläsel, T.; Villinger, A.; Sosnovskikh, V. Ya.; Iaroshenko, V. O.; Langer, P. Org. Biomol. Chem. 2015, 13, 729–750. doi:10.1039/C4OB01730G
    Return to citation in text: [1]
  29. Beccalli, E. M.; Marchesini, A.; Pilati, T. Tetrahedron 1993, 49, 4741–4758. doi:10.1016/S0040-4020(01)81301-6
    Return to citation in text: [1]
  30. Albertshofer, K.; Tan, B.; Barbas, C. F., III. Org. Lett. 2012, 14, 1834–1837. doi:10.1021/ol300441z
    Return to citation in text: [1]
  31. Cao, S.-H.; Zhang, X.-C.; Wei, Y.; Shi, M. Eur. J. Org. Chem. 2011, 2668–2672. doi:10.1002/ejoc.201100017
    Return to citation in text: [1]
  32. Levy, J.; Royer, D.; Guilhem, J.; Cesario, M.; Pascard, C. Bull. Soc. Chim. Fr. 1987, 193–198.
    Return to citation in text: [1] [2] [3]
  33. Kobayashi, G.; Furukawa, S.; Matsuda, Y.; Natsuki, R. Yakuguku Zasshi 1969, 89, 58–63.
    Return to citation in text: [1]
  34. Mercury 3.1 is available from http://www.ccdc.cam.ac.uk/mercury/.
    Return to citation in text: [1]
  35. Sheldrick, G. M. Acta Crystallogr., Sect. A 2008, 64, 112–122. doi:10.1107/S0108767307043930
    Return to citation in text: [1]

© 2015 Irgashev et al; licensee Beilstein-Institut.
This is an Open Access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The license is subject to the Beilstein Journal of Organic Chemistry terms and conditions: (http://www.beilstein-journals.org/bjoc)

Back to Article List

Other Beilstein-Institut Open Science Activities

Keep Informed

RSS Feed

Subscribe to our Latest Articles RSS Feed.


Follow the Beilstein-Institut


Twitter: @BeilsteinInst